Lobbying client
EVOFEM BIOSCIENCES
Biopharmaceutical company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.
Filings
12
Filed by
3
Reported in-house
—
Reported by firms
$280,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2022
Filings
12 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination (No Activity) 4th Quarter 2022
|
MERCURY PUBLIC AFFAIRS, LLC | — reported |
|
3rd Quarter - Report 3rd Quarter 2022
|
MERCURY PUBLIC AFFAIRS, LLC | — reported |
|
2nd Quarter - Report 2nd Quarter 2022
|
MERCURY PUBLIC AFFAIRS, LLC | $10,000 reported |
|
Registration 2nd Quarter 2022
|
MERCURY PUBLIC AFFAIRS, LLC | — reported |
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2021
|
RICCHETTI INCORPORATED | — reported |
|
3rd Quarter - Termination 3rd Quarter 2021
|
RAMPY NORTHRUP LLC | $40,000 reported |
|
2nd Quarter - Report 2nd Quarter 2021
|
RAMPY NORTHRUP LLC | $40,000 reported |
|
2nd Quarter - Report 2nd Quarter 2021
|
RICCHETTI INCORPORATED | $80,000 reported |
|
Registration 2nd Quarter 2021
|
RAMPY NORTHRUP LLC | — reported |
|
1st Quarter - Report 1st Quarter 2021
|
RICCHETTI INCORPORATED | $80,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| RICCHETTI INCORPORATED | 4 | $190,000 |
| RAMPY NORTHRUP LLC | 2 | $80,000 |
| MERCURY PUBLIC AFFAIRS, LLC | 3 | $10,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 10 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.